Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

por Galamb, O, Spisák, S, Sipos, F, Tóth, K, Solymosi, N, Wichmann, B, Krenács, T, Valcz, G, Tulassay, Z, Molnár, B
Publicado 2010